For one thing, Qiu et al. (6) revealed that the binding of the NF-κB p65 subunit to the myostatin promoter, which could result from hyperammonemia, facilitated the transcription of the myostatin gene. The gene discussed is MSTN; the disease is Hyperammonemia.